Discover innovative solutions to the key challenges of the drug safety industry
Yola Moride | Associate Professor Université de Montréal
Yola Moride has received degrees in Genetics (MSc) and Pharmacoepidemiology (PhD) from McGill University and has trained as a Post-doctoral Fellow at the Pharmacovigilance Centre at the University of Bordeaux (France). Professor Moride has over 18 years of experience in the conduct of observational studies. She holds academic appointments at Université de Montréal, McGill University, and University of Bordeaux and has served as scientific expert for regulatory authorities such as Health Canada and the European Medicines Agency (EMEA). She recently completed her term as President of the International Society for Pharmacoepidemiology (ISPE). She is President of YOLARx Consultants Inc, a consulting company that offers services in pharmacoepidemiology and therapeutic risk management to the pharmaceutical industry and regulatory authorities in North America and Europe.
Share this
Appearances at this years' conference:
Day Two - Thursday 19th April 2012
@ 09.15
The role of pharmacoepidemiology in drug safety
• Real world examples showing the vital role pharmacoepidemiology plays in ensuring patient safety
› Yola Moride, Associate Professor, Université de Montréal